213 related articles for article (PubMed ID: 35628622)
21. SELEX based aptamers with diagnostic and entry inhibitor therapeutic potential for SARS-CoV-2.
Halder S; Thakur A; Keshry SS; Jana P; Karothia D; Das Jana I; Acevedo O; Swain RK; Mondal A; Chattopadhyay S; Jayaprakash V; Dev A
Sci Rep; 2023 Sep; 13(1):14560. PubMed ID: 37666993
[TBL] [Abstract][Full Text] [Related]
22. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites.
Qiao B; Olvera de la Cruz M
ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067
[TBL] [Abstract][Full Text] [Related]
23. Structure- and Interaction-Based Design of Anti-SARS-CoV-2 Aptamers.
Mironov V; Shchugoreva IA; Artyushenko PV; Morozov D; Borbone N; Oliviero G; Zamay TN; Moryachkov RV; Kolovskaya OS; Lukyanenko KA; Song Y; Merkuleva IA; Zabluda VN; Peters G; Koroleva LS; Veprintsev DV; Glazyrin YE; Volosnikova EA; Belenkaya SV; Esina TI; Isaeva AA; Nesmeyanova VS; Shanshin DV; Berlina AN; Komova NS; Svetlichnyi VA; Silnikov VN; Shcherbakov DN; Zamay GS; Zamay SS; Smolyarova T; Tikhonova EP; Chen KH; Jeng US; Condorelli G; de Franciscis V; Groenhof G; Yang C; Moskovsky AA; Fedorov DG; Tomilin FN; Tan W; Alexeev Y; Berezovski MV; Kichkailo AS
Chemistry; 2022 Feb; 28(12):e202104481. PubMed ID: 35025110
[TBL] [Abstract][Full Text] [Related]
24. Structural and simulation analysis of hotspot residues interactions of SARS-CoV 2 with human ACE2 receptor.
Veeramachaneni GK; Thunuguntla VBSC; Bobbillapati J; Bondili JS
J Biomol Struct Dyn; 2021 Jul; 39(11):4015-4025. PubMed ID: 32448098
[TBL] [Abstract][Full Text] [Related]
25. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
Front Immunol; 2021; 12():691715. PubMed ID: 34149735
[TBL] [Abstract][Full Text] [Related]
26. Effect of mutation on structure, function and dynamics of receptor binding domain of human SARS-CoV-2 with host cell receptor ACE2: a molecular dynamics simulations study.
Dehury B; Raina V; Misra N; Suar M
J Biomol Struct Dyn; 2021 Nov; 39(18):7231-7245. PubMed ID: 32762417
[TBL] [Abstract][Full Text] [Related]
27. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
28. A Novel Therapeutic Peptide Blocks SARS-CoV-2 Spike Protein Binding with Host Cell ACE2 Receptor.
Rajpoot S; Ohishi T; Kumar A; Pan Q; Banerjee S; Zhang KYJ; Baig MS
Drugs R D; 2021 Sep; 21(3):273-283. PubMed ID: 34324175
[TBL] [Abstract][Full Text] [Related]
29. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
[TBL] [Abstract][Full Text] [Related]
30. Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding.
Byrnes JR; Zhou XX; Lui I; Elledge SK; Glasgow JE; Lim SA; Loudermilk RP; Chiu CY; Wang TT; Wilson MR; Leung KK; Wells JA
mSphere; 2020 Sep; 5(5):. PubMed ID: 32938700
[TBL] [Abstract][Full Text] [Related]
31. Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding.
Ahamad S; Kanipakam H; Gupta D
J Biomol Struct Dyn; 2022 Jan; 40(1):263-275. PubMed ID: 32851910
[TBL] [Abstract][Full Text] [Related]
32. Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.
Basit A; Ali T; Rehman SU
J Biomol Struct Dyn; 2021 Jul; 39(10):3605-3614. PubMed ID: 32396773
[TBL] [Abstract][Full Text] [Related]
33. Computational Analysis of Mutations in the Receptor-Binding Domain of SARS-CoV-2 Spike and Their Effects on Antibody Binding.
Bozdaganyan ME; Shaitan KV; Kirpichnikov MP; Sokolova OS; Orekhov PS
Viruses; 2022 Jan; 14(2):. PubMed ID: 35215888
[TBL] [Abstract][Full Text] [Related]
34. Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2.
Choi KE; Kim JM; Rhee J; Park AK; Kim EJ; Kang NS
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445414
[TBL] [Abstract][Full Text] [Related]
35. Multi-epitope vaccine against SARS-CoV-2 applying immunoinformatics and molecular dynamics simulation approaches.
Jyotisha ; Singh S; Qureshi IA
J Biomol Struct Dyn; 2022 Apr; 40(7):2917-2933. PubMed ID: 33164664
[TBL] [Abstract][Full Text] [Related]
36. Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies.
Mercurio I; Tragni V; Busto F; De Grassi A; Pierri CL
Cell Mol Life Sci; 2021 Feb; 78(4):1501-1522. PubMed ID: 32623480
[TBL] [Abstract][Full Text] [Related]
37. A Universal DNA Aptamer that Recognizes Spike Proteins of Diverse SARS-CoV-2 Variants of Concern.
Zhang Z; Li J; Gu J; Amini R; Stacey HD; Ang JC; White D; Filipe CDM; Mossman K; Miller MS; Salena BJ; Yamamura D; Sen P; Soleymani L; Brennan JD; Li Y
Chemistry; 2022 Mar; 28(15):e202200078. PubMed ID: 35084794
[TBL] [Abstract][Full Text] [Related]
38. Computational design and modeling of nanobodies toward SARS-CoV-2 receptor binding domain.
Yang J; Zhang Z; Yang F; Zhang H; Wu H; Zhu F; Xue W
Chem Biol Drug Des; 2021 Jul; 98(1):1-18. PubMed ID: 33894099
[TBL] [Abstract][Full Text] [Related]
39. The spike-ACE2 binding assay: An in vitro platform for evaluating vaccination efficacy and for screening SARS-CoV-2 inhibitors and neutralizing antibodies.
Zhang S; Gao C; Das T; Luo S; Tang H; Yao X; Cho CY; Lv J; Maravillas K; Jones V; Chen X; Huang R
J Immunol Methods; 2022 Apr; 503():113244. PubMed ID: 35218866
[TBL] [Abstract][Full Text] [Related]
40. Corilagin and 1,3,6-Tri-
Binette V; Côté S; Haddad M; Nguyen PT; Bélanger S; Bourgault S; Ramassamy C; Gaudreault R; Mousseau N
Phys Chem Chem Phys; 2021 Jul; 23(27):14873-14888. PubMed ID: 34223589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
